Blood-clotting factors are generally assayed for their biological activity. The recent discovery, however, that some haemorrhagic conditions stem from the existence of structurally abnormal clotting factors rather than their deficiency or absence creates a need for additional assay methods. Thus abnormal forms offibrinogen (Blomback eta/., 1968) factor VIII (Denson et al., 1969) , factor IX (Denson et al., 1968) and factor X (Denson et al., 1970) have been reported. If the structural abnormality is limited, as in the case of fibrinogen Detroit (Blomback et al., 1968), then abnormal factors could interact with antibodies raised against the corresponding normal molecule. Consequently, it appears desirable to assay clotting factors from patients with haemorrhagic disorders by radioimmunoassay as well as by conventional clotting tests. Radioimmunoassays for fibrinogen (Catt etal., 1968), prothrombin (Johnston etal., 1972) and theantihaemophilic factor, factor VIII (Hoyer, 1972) have been reported. The purpose of this present work was to develop a radioimmunoassay for factor X.
Rabbits were immunized against bovine factor X by multi-site subcutaneous injection. Immunoglobulins G, containing the resultant antibodies, were purified and coupled to Sepharose 4B as described by Murphy et al. (1973) . The product is subsequently referred to as antibody-Sepharose conjugate, 1 mg of which was sufficient to bind 50 % of the amount (1.7ng) of labelled antigen used for radioimmunoassay. Radioimmunoassay mixtures comprised a suspension of antibody Sepharose conjugate (0.1 ml), labelled antigen (0.lml) in Michaelis buffer (Michaelis, 1931) , pH7.3, diluted to lml with buffer.
The buffer contained 1 % human serum albumin to minimize non-specific binding to the polypropylene assay tubes (capacity 2.5ml). The assay tubes were stoppered and rotated end over end throughout incubation for 20h at 5°C. Radioactivity bound to the antibody-Sepharose conjugate was counted after repeated centrifugation and washing with the above buffer containing 5 % Sepharose. The inert agarose particles facilitated retention of the conjugate during removal of the supernatant. Concentrations of factor X as low as 20ng/ml could be detected; the operative range, however, was 30-500ng/ml.
No crossreactivity was observed with pure bovine prothrombin, thrombin or trypsin in concentrations up to lOOfig/ml. The immunoreactivity of factor Xa, however, was identical with that of factor X indicating that the immunogenic site for factor X did not reside in the activation peptide. The results further strengthen the evidence that factor Xa and thrombin are not both derived from the same molecule. Direct assay of fresh bovine plasma gave a concentration of factor X of 1 mg/100mI comparable with that reported by Esnouf et al. (1973 Lactoperoxidase (EC 1.11.1.7), in the presence of dilute H202, has been used with advantage in place of chemical oxidants for the incorporation of iodine into tyrosyl residues of proteins and polypeptides (Marchalonis, 1969; Holohan et al., 1973~) . It has also been shown (Holohan et al., 19736 ) that secretin, which does not contain tyrosine, and poly-(L-histidine) can be iodinated in the presence of lactoperoxidase. Substitution occurred in the N-terminal histidine residue of secretin, a result which was not entirely unexpected, since histidine residues had previously been assumed to incorporate iodine to a limited extent when iodinated in the presence of chloramine-.r as described by Hunter & Greenwood (1962) . We have now determined the site of substitution in the imidazole ring after the iodination of poly-(L-histidine) in the presence of lactoperoxidase.
The reaction mixture for iodination contained poly-(L-histidine) (Miles-Yeda Ltd., Rehovoth, Israel; mol.wt. 8000-11 000) (20mg) and lactoperoxidase (0.3mg) in 0.2M-sodium acetate-acetic acid buffer (30ml), pH5.6. NaI (IlmM, 5ml) and 86rn~-H,O* (2ml) were added portionwise during 2h with constant stirring. Iodination was stopped by the addition of ~M -N~O H (lml). The precipitated product was collected by centrifugation, washed successively with ethanol (30ml) and ether (30ml), dried, and dissolved in a mixture of CH302H (0.1 ml) and ZH20 (0.4 ml).
Proton magnetic resonance spectra (Fig. 1 ) of poly-(L-histidine) and the iodinated product were obtained on a HA-100 n.m.r. spectrometer (Varian Associates) at a sweep width of 1OOOHz. The two absorption bands in the spectrum of poly-(L-histidine) (6=8.8 and 7.5p.p.m.) stem from the protons at C-2 and C-4 respectively in the imidazole ring. This assignment is based on the observations of McDonald & Phillips (1963) on the n.m.r. spectrum of histidine. The spectrum of the iodinated product, however, contains an additional band slightly upfield from the band due to the proton at C-2. The intensity of this peak was found to be proportional to the degree of incorporation of iodine as determined by microanalysis. The new peak is attributed, therefore, to the proton on the carbon atom which is not substituted by iodine. Bensusan & Naidu (1967) showed that the band caused by the proton at C-2 in 4-iodohistidine was shifted slightly upfield relative to the corresponding band in histidine. Moreover, the bands caused by
